AG00BXIN

38562-01-5 | Prostaglandin F2a Tris Salt

Chemical structure of Prostaglandin F2a Tris Salt, CAS 38562-01-5
AG00BXIN
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 38562-01-5
Catalog Number AG00BXIN(AGN-PC-0RGV5Q)
Chemical Name Prostaglandin F2a Tris Salt
EC Number 254-002-3
IUPAC Name 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
InChI InChI=1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1
InChI Key IYGXEHDCSOYNKY-RZHHZEQLSA-N
MDL Number MFCD00077863
Molecular Formula C24H45NO8
Molecular Weight 475.6160
NSC Number 196515
SMILES CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=CCCCC(O)=O.OCC(CO)(N)CO
UNII CT6BBQ5A68
Synonyms
dinoprost tromethamine, Lutalyse, Minprostin F2 Alpha, PGF2alpha tromethamine, prostaglandin F2alpha tromethamine, Prostin F2, Prostin F2 Alpha, dinoprost tromethamine, Dinolytic, PGF2-alpha tham, Zinoprost, Dinoprost trometamol, Prostalmon F, Prostin F2 alpha, Lutalyse, 38562-01-5, PGF2alpha THAM, Pronalgon F, Prostaglandin F2alpha tham, Panacelan F tromethamine salt, Prostaglandin F2-alpha THAM, Prostaglandin F2a tromethamine, Dinoprost, trometamol salt, THAM PGF2-alpha, Ensaprost, Lutalyse (Veterinary), PGF2-alpha tris salt, PGF2-alpha tromethamine, Enzaprost F compd. with trisamine, PGF2-alpha tromethamine salt, Protaglandin F2-alpha-tham salt, Prostaglandin F2-alpha THAM salt, Prostaglandin F2-alpha tromethamine, Tromethamine prostaglandin F2-alpha, UNII-CT6BBQ5A68, Prostaglandin F(sub 2a) tromethamine, Dinoprost (tromethamine salt), U-14,583E, C20H34O5.C4H11NO3, EINECS 254-002-3, Prostamate, U 14585, NSC 196515, CT6BBQ5A68, MLS000028821, CHEBI:31502, 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, tham, 7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, tromethamine salt, (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), SMR000058792, Prostaglandin F2|A, 1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oate (salt), Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-, compd. with trimethylolaminomethane, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), PGF2alpha-Tris, 2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid, PGF2alpha tromethamine, Prostaglandin F2a tris salt, Dinoprost tromethamine [USAN:JAN], Prostin F2 alpha (TN), Dinoprost Tromethamine Salt, prostaglandin F2alpha tromethamine, Dinoprost tromethamine (JAN/USP), Prostaglandin F2?, 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid, glandin; tris buffer, dinoprost-tromethamine, PROSTAGLANDIN F2ALPHA TRIS SALT, Dinoprost tromethamine [USAN:USP:JAN], PGF2.alpha. THAM, PGF2ALPHA-THAM, Prostaglandin F-2alpha tromethamine salt, ProstaglandinF2atrissalt, U-14583E, Opera_ID_1888, 7-[3, tromethamine salt, SCHEMBL203377, Prostaglandin F2.alpha. THAM, AC1NR011, CHEMBL1200896, REGID_for_CID_5282415, HMS2230J05, AN-110, HY-12956A, MFCD00077863, NSC196515, Prostaglandin F(2)(alpha) tris salt, AKOS015920234, AT-5102, DB01160, NSC-196515, RP17760, (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt, Prostin F2 alpha,3-propanediol (1:1), BR-72816, CC-27068, Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-,compd. with trimethylolaminomethane, Prostaglandin F2alpha (tromethamine salt), U-14, LS-125841, B7617, C12786, D01352, Prostaglandin F2.alpha.,3-propanediol (1:1), 562D015, 562P015, SR-01000946463, SR-01000946463-1, WLN: L5TJ AQ B2U4VQ C1U1YQ5 DQ &Q1XZ1Q1Q, Prostaglandin F2alpha tris salt, >=99%, synthetic, powder, Prostaglandin F2alpha tris salt, synthetic, cell culture tested, Dinoprost trometamol, European Pharmacopoeia (EP) Reference Standard, 5-Heptenoic acid,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, THAM, Dinoprost compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), Dinoprost tromethamine, United States Pharmacopeia (USP) Reference Standard, 9?,11?,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic acid tris(hydroxymethyl)aminomethane salt, (E,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)@component of Prostin F2 Alpha, injectable, Prosta-5, (5Z,9.alpha.,11.alpha.,13E,15S)-9,11,15-trihydroxy- compd. with (trimethylolamino)methane, Prosta-5, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), prostaglandin F2alpha, Dinoprosttromethamine, D04RGA, Prostaglandin F2? tris salt, MLS003107056, CID5282415, CS-4233, 583E, 2-Amino-2-(hydroxymethyl)propane-1,3-diol, C20-H34-O5.C4-H11-N-O3, U 14583, (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid, Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9?,11?,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited